BenevolentAI Begins Trading On Euronext Amsterdam : vimarsan

/PRNewswire/ -- BenevolentAI (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, announces that trading in its shares is...

Related Keywords

New York , United States , Australia , Japan , Canada , London , City Of , United Kingdom , Michael Zaoui , Joanna Shields , Olivier Brandicourt , Jean Raby , Goldman Sachs International , Astrazeneca , Meagher Flom United Kingdom , Zaoui Co , Latham Watkins London , Euronext Amsterdam , Business Combination , Natixis Investment Managers , Benevolent Platform , Chief Executive Officer , Ordinary Shares , Sachs International , Financial Sector Supervisory Commission , Commission De Surveillance , Secteur Financier , Member State , European Economic , European Economic Area , Relevant Member , Relevant Member States , Prospectus Regulation , Benevolentai ,